Roche launch the new BenchMark® ULTRA

New equipment release from Roche

With the acquisition of Ventara Medical Systems, Roche hopes to move several steps further forward in their goal for personalised medicine that improves diagnostics and ultimately, clinical outcomes.

The new Ventara BenchMark® ULTRA from Roche
The new Ventara BenchMark® ULTRA from Roche

The systems acquired with Ventara mean Roche can now add tissue analysis to its impressive list of blood and serum based diagnostic tests.
BenchMark® ULTRA from Ventara Medical Systems is launched in Europe and is the new generation of in IHC/ISH staining instrumentation to improve throughput in the pathology/histology lab.
Using 30 individual slide processors, its patient centric workflow integrates continuous and random access for real time STAT processing. Turnaround times are significantly reduced, resulting in faster reporting of patient results and enabling the next generation in lean laboratory workflow. The system integrates into the laboratory information system for rapid and accurate transfer of data.

For more information see: http://www.ventanamed.com
 

21.11.2008

Read all latest stories

Related articles

Photo

Image analysis integration

Roche opens access to digital pathology tools

Roche announced the introduction of the Roche Digital Pathology Open Environment that allows software developers to easily integrate their image analysis tools for tumour tissue with Roche’s uPath…

Photo

Sponsored • Automation

Proven Practices for Lab Automation Success

Cost constraints, higher workloads, and a shortage of qualified staff are three distinct market trends driving demand for greater efficiency in the laboratory. The goals of automation are to make…

Photo

Article •

Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche

Samsung BioLogics today announced that Samsung BioLogics and F. Hoffmann-La Roche have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche's…

Related products

Subscribe to Newsletter